Real-time enrollment status for this adverse pregnancy outcomes clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:21 PM UTC
| NCT Number | NCT03936335 |
| Recruiting Status | Recruiting |
| Condition | Adverse Pregnancy Outcomes |
| Phase | Clinical Trial |
| Target Enrollment | 3,930 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | August 3, 2025 (Aug 3, 2025) |
As of July 13, 2026: Clinical trial NCT03936335 is currently recruiting participants. This clinical trial study for adverse pregnancy outcomes is actively seeking new participants at 1 location across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03936335 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03936335 was last updated Aug 3, 2025 (August 3, 2025). HelloStudys verifies this status automatically.